11 results on '"Tessadrelli A"'
Search Results
2. Effect of breathing pattern on the pressure-time product calculation
- Author
-
NATALINI, G., MARCHESINI, M., TESSADRELLI, A., ROSANO, A., CANDIANI, A., and BERNARDINI, A.
- Published
- 2004
3. Biologic activity of tamoxifen at low doses in healthy women
- Author
-
Decensi, Andrea, Bonanni, Bernardo, Guerrieri-Gonzaga, Aliana, Gandini, Sara, Robertson, Chris, Johansson, Harriet, Travaglini, Roberto, Sandri, Maria Teresa, Tessadrelli, Antonella, Farante, Gabriel, Salinaro, Federica, Bettega, Donato, Barreca, Antonina, Boyle, Peter, Costa, Alberto, and Veronesi, Umberto
- Subjects
Tamoxifen -- Adverse and side effects ,Breast cancer -- Prevention ,Drugs -- Dosage and administration ,Health - Abstract
Background: Results of a clinical trial recently completed in the United States indicate that administration of tamoxifen (20 mg/day) to women at risk can reduce breast cancer incidence by approximately 50% but is associated with an increased risk of developing endometrial cancer and venous thromboembolic events. Since these adverse effects may be dose related, we investigated the effect of tamoxifen on several biomarkers when the drug was given at doses lower than those currently in use. Methods: In two sequential experiments, 127 healthy hysterectomized women aged 35-70 years were randomly assigned to one of the following four treatment arms: placebo (n = 31) or tamoxifen at 20 mg/day (n = 30) (first experiment); or tamoxifen at 10 mg/day (n = 34) or tamoxifen at 10 mg/ alternate days (n = 32) (second experiment). Baseline and 2-month measurements of the following parameters were compared: 1) total cholesterol (primary end point) and other surrogate markers of cardiovascular disease, e.g., low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and lipoprotein(a); 2) blood cell count; 3) fibrinogen; 4) antithrombin III; 5) osteocalcin; and, 6) in a subgroup of 103 women, insulin-like growth factor-I (IGF-I), a possible surrogate marker for breast cancer. Results: After adjustment for the baseline values, there were reductions in circulating levels of total cholesterol and IGF-I of the same magnitude in all three tamoxifen treatment arms. A similar pattern was observed for most of the other parameters. In the placebo arm, fibrinogen level, which showed a decrease, was the only parameter exhibiting change. Conclusions: Up to a 75% reduction in the conventional dose of tamoxifen (i.e., 20 mg/day) does not affect the activity of the drug on a large number of biomarkers, most of which are surrogate markers of cardiovascular disease. This study was hypothesis generating, and larger studies are warranted to assess the efficacy of tamoxifen at low doses. [J Natl Cancer Inst 1998;90:1461-7]
- Published
- 1998
4. Effect of breathing pattern on the pressure-time product calculation
- Author
-
Achille Bernardini, Antonio Rosano, A. Tessadrelli, Andrea Candiani, M. Marchesini, and Giuseppe Natalini
- Subjects
Male ,Time Factors ,animal structures ,Respiratory rate ,Respiratory physiology ,Work of breathing ,Pressure ,Humans ,Medicine ,Intermittent Positive-Pressure Breathing ,Tidal volume ,Aged ,Work of Breathing ,Analysis of Variance ,Mechanical load ,business.industry ,Respiration ,Reproducibility of Results ,General Medicine ,Respiratory Function Tests ,enzymes and coenzymes (carbohydrates) ,Anesthesiology and Pain Medicine ,Intermittent positive pressure breathing ,Anesthesia ,Respiratory Mechanics ,Respiratory Physiological Phenomena ,Breathing ,Female ,business ,Respiratory minute volume ,Biomedical engineering - Abstract
Background: The pressure-time product (PTP) is often used to compare conditions with different breathing patterns. Being the pressure-time product calculated with pressures changes over a minute, mechanical load and inspiration time per minute should be its main determinants. The aim of this study was to investigate if the method of PTP computation is affected by the breathing pattern when mechanical load and inspiratory time per minute are constant. Methods: Respiratory mechanics and the PTP developed by the ventilator were calculated in 10 mechanically ventilated patients at three different respiratory rate/tidal volume combinations, provided that minute ventilation and inspiratory time per minute were constant. Results: The static elastance did not change at different tidal volumes. Despite the constant elastic load over a minute, the elastic PTP showed an increment greater than 200% from the higher to the lower respiratory rate, responsible for approximately 80% of the whole PTP increment. On the contrary a ‘corrected’ elastic PTP (calculated using the square root of the elastic pressure-time area), the elastic double product of the respiratory system and the mean elastic pressure per minute, did not significantly change. Conclusions: Changes in breathing pattern markedly affected the PTP independently by the mechanical load and the inspiratory time per minute. In these conditions it could not correctly estimate the metabolic cost of breathing. The use of a ‘corrected’ PTP, the mean inspiratory pressure per minute or the double product of the respiratory system, could overcome this limitation.
- Published
- 2004
- Full Text
- View/download PDF
5. Biologic Activity of Tamoxifen at Low Doses in Healthy Women
- Author
-
Aliana Guerrieri-Gonzaga, Alberto Costa, Peter Boyle, Andrea Decensi, Antonina Barreca, Sara Gandini, Chris Robertson, Federica Salinaro, Roberto Travaglini, Harriet Johansson, G. Farante, Maria Teresa Sandri, Umberto Veronesi, Antonella Tessadrelli, D. Bettega, and Bernardo Bonanni
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Antineoplastic Agents, Hormonal ,Osteocalcin ,Hysterectomy ,Placebo ,Gastroenterology ,Drug Administration Schedule ,chemistry.chemical_compound ,Breast cancer ,Reference Values ,Internal medicine ,medicine ,Humans ,Insulin-Like Growth Factor I ,Adverse effect ,Aged ,Surrogate endpoint ,Cholesterol ,business.industry ,Endometrial cancer ,Estrogen Antagonists ,Middle Aged ,Antiestrogen ,medicine.disease ,Lipids ,Blood Coagulation Factors ,Blood Cell Count ,Tamoxifen ,Endocrinology ,Oncology ,chemistry ,Female ,business ,Biomarkers ,medicine.drug - Abstract
Background: Results of a clinical trial recently completed in the United States indicate that administration of tamoxifen (20 mg/day) to women at risk can reduce breast cancer incidence by approximately 50% but is associated with an increased risk of developing endometrial cancer and venous thromboembolic events. Since these adverse effects may be dose related, we investigated the effect of tamoxifen on several biomarkers when the drug was given at doses lower than those currently in use. Methods: In two sequential experiments, 127 healthy hysterectomized women aged 35-70 years were randomly assigned to one of the following four treatment arms: placebo (n = 31) or tamoxifen at 20 mg/day (n = 30) (first experiment); or tamoxifen at 10 mg/day (n = 34) or tamoxifen at 10 mg/ alternate days (n = 32) (second experiment). Baseline and 2-month measurements of the following parameters were compared: 1) total cholesterol (primary end point) and other surrogate markers of cardiovascular disease, e.g., low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and lipoprotein(a); 2) blood cell count; 3) fibrinogen; 4) antithrombin III; 5) osteocalcin; and, 6) in a subgroup of 103 women, insulin-like growth factor-I (IGF-I), a possible surrogate marker for breast cancer. Results : After adjustment for the baseline values, there were reductions in circulating levels of total cholesterol and IGF-I of the same magnitude in all three tamoxifen treatment arms. A similar pattern was observed for most of the other parameters. In the placebo arm, fibrinogen level, which showed a decrease, was the only parameter exhibiting change. Conclusions: Up to a 75% reduction in the conventional dose of tamoxifen (i.e., 20 mg/day) does not affect the activity of the drug on a large number of biomarkers, most of which are surrogate markers of cardiovascular disease. This study was hypothesis generating, and larger studies are warranted to assess the efficacy of tamoxifen at low doses.
- Published
- 1998
- Full Text
- View/download PDF
6. Combination therapy with leuprolide acetate and tamoxifen in refractory ovarian cancer
- Author
-
A. Lopez, John J. Kavanagh, A. Tessadrelli, Andrzej P. Kudelka, Creighton L. Edwards, M. Hord, and Ralph S. Freedman
- Subjects
medicine.medical_specialty ,Combination therapy ,business.industry ,medicine.medical_treatment ,Urology ,Obstetrics and Gynecology ,Pharmacology ,medicine.disease ,Oncology ,Refractory ,Ovarian carcinoma ,Toxicity ,medicine ,Hormonal therapy ,Hormone therapy ,Ovarian cancer ,business ,Tamoxifen ,medicine.drug - Abstract
To determine the activity of combination hormonal therapy for platinum-resistant ovarian carcinoma, we treated 20 patients with leuprolide acetate 7.5 mg intramuscularly once a month and tamoxifen 20 mg orally twice a day. Among the 17 evaluable patients, two patients (12%; 95% CI: 0–27) had a partial response, each lasting 7 months. An additional five patients (29%; 95% CI: 8–51) experienced disease stabilization with a median duration of 5 months. This response rate is not significantly different from previously published studies using either leuprolide acetate or tamoxifen alone. The median survival duration was 14.4 months and this was not significantly different from that of our previous study with high-dose Taxol (P = 0.0668). The treatment was well-tolerated, with minimal toxicity. Combination hormone therapy with leuprolide acetate and tamoxifen does not result in increased activity compared with either drug used alone for platinum-refractory ovarian carcinoma. However, hormonal therapy should remain an important consideration for this disease since it has documented activity with minimal associated toxicity.
- Published
- 1996
- Full Text
- View/download PDF
7. Effect of tidal volume and respiratory rate on the power of breathing calculation
- Author
-
Andrea Candiani, Antonio Rosano, A. Tessadrelli, M. Marchesini, Achille Bernardini, and Giuseppe Natalini
- Subjects
Male ,Respiratory rate ,Vital Capacity ,Respiratory physiology ,Positive-Pressure Respiration ,Work of breathing ,Tidal Volume ,Medicine ,Humans ,Respiratory system ,Tidal volume ,Aged ,Alternative methods ,Mechanical load ,business.industry ,Airway Resistance ,General Medicine ,Mechanics ,Middle Aged ,Respiration, Artificial ,Elasticity ,Anesthesiology and Pain Medicine ,Anesthesia ,Respiratory Mechanics ,Female ,business ,Respiratory minute volume - Abstract
Background: The power of breathing (PoB) is used to estimate the mechanical workload of the respiratory system. Aim of this study was to investigate the effect of different tidal volume-respiratory rate combinations on the PoB when the elastic load is constant. In order to assure strict control of the experimental conditions, the PoB was calculated on an airway pressure-volume curve in mechanically ventilated patients. Methods: Ten patients received three different tidal volume-respiratory rate combinations while minute ventilation was constant. Respiratory mechanics, PoB and its elastic and resistive components were calculated. Alternative methods to estimate the elastic workload were assessed: elastic work of breathing per litre per minute, elastic workload index (the square root of elastic work of breathing multiplied by respiratory rate) and elastic double product of the respiratory system (the elastic pressure multiplied by respiratory rate). Results: Despite constant elastance and minute ventilation, the elastic PoB showed an increment greater than 200% from the lower to the greater tidal volume, accounting for approximately 80% of the whole PoB increment. On the contrary, elastic work of breathing per litre per minute, elastic workload index and elastic double product did not change. Conclusion: Changes in breathing pattern markedly affect the PoB despite constant mechanical load. Other indexes could assess the elastic workload without tidal volume dependence. Power of breathing use should be avoided to compare different mechanical loads or efficiencies of the respiratory muscles when tidal volume is variable.
- Published
- 2005
8. Modelli matematici della comunicazione musicale nel pensiero di Giovanni Melzi
- Author
-
Allevi, Elisabetta, Fiorini, G., and Tessadrelli, L.
- Published
- 1995
9. Low-dose tamoxifen trial in healthy women
- Author
-
Andrea Decensi, A. Tessadrelli, Chris Robertson, Roberto Travaglini, A. Guerrieri Gonazaga, G. Farante, Aurora Costa, B Bonanni, D. Bettega, and Maria Teresa Sandri
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Internal medicine ,Low dose ,medicine ,business ,Tamoxifen ,medicine.drug - Published
- 1997
- Full Text
- View/download PDF
10. Low-dose tamoxifen trial in healthy women
- Author
-
Bonanni, B., primary, Decensi, A., additional, Travaglini, R., additional, Guerrieri Gonazaga, A., additional, Tessadrelli, A., additional, Sandri, M.T., additional, Farante, G., additional, Bettega, D., additional, Robertson, Chris, additional, and Costa, A., additional
- Published
- 1997
- Full Text
- View/download PDF
11. Combination therapy with leuprolide acetate and tamoxifen in refractory ovarian cancer
- Author
-
Lopez, A., primary, Tessadrelli, A., additional, Kudelka, A.P., additional, Edwards, C.L., additional, Freedman, R.S., additional, Hord, M., additional, and Kavanagh, J.J., additional
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.